- Home
- MRK vs DAVEW Comparison
MRK vs DAVEW Comparison
Compare MRK & DAVEW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MRK | DAVEW |
|---|---|---|
| Founded | 2000 | 2015 |
| Country | United States | United States |
| Employees | N/A | 274 |
| Industry | Biotechnology: Pharmaceutical Preparations | Retail: Computer Software & Peripheral Equipment |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.2B | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | MRK | DAVEW |
|---|---|---|
| Price | $106.64 | $0.90 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $111.93 | N/A |
| AVG Volume (30 Days) | ★ 15.7M | 46.1K |
| Earning Date | 02-03-2026 | 03-06-2025 |
| Dividend Yield | ★ 3.24% | N/A |
| EPS Growth | ★ 58.08 | N/A |
| EPS | ★ 7.56 | 3.12 |
| Revenue | ★ $64,235,000,000.00 | $319,355,000.00 |
| Revenue This Year | $1.97 | N/A |
| Revenue Next Year | $4.96 | N/A |
| P/E Ratio | ★ $13.90 | $34.00 |
| Revenue Growth | 1.68 | ★ 30.00 |
| 52 Week Low | $73.31 | $0.28 |
| 52 Week High | $105.84 | $0.32 |
Technical Indicators
Market Signals| Indicator | MRK | DAVEW |
|---|---|---|
| Relative Strength Index (RSI) | 70.45 | 60.96 |
| Support Level | $96.79 | $0.64 |
| Resistance Level | $100.94 | $0.72 |
| Average True Range (ATR) | 2.47 | 0.08 |
| MACD | 0.24 | 0.04 |
| Stochastic Oscillator | 95.96 | 99.98 |
Price Performance
Historical ComparisonAbout MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
About DAVEW Dave Inc.
Dave Inc is a financial services company. It is engaged in offering banking app that offers its customers banking, financial insights, overdraft protection, building credit and finding side gigs.